NCT04785287 2026-03-03Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesM.D. Anderson Cancer CenterPhase 1/2 Terminated13 enrolled
NCT04008797 2026-02-27A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorEisai Inc.Phase 1/2 Active not recruiting301 enrolled
NCT05438420 2026-02-24Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid TumorsQurient Co., Ltd.Phase 1/2 Active not recruiting120 enrolled
NCT06608940 2026-02-19BC3402 w/ Tremelimumab + Durvalumab (STRIDE) in Hepatocellular CarcinomaCase Comprehensive Cancer CenterPhase 1/2 Withdrawn
NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT05070247 2026-01-22A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTakedaPhase 1/2 Terminated61 enrolled 29 charts
NCT07341737 2026-01-15SL-28 for Advanced Solid TumoursSecond Life TherapeuticsPhase 1/2 Not yet recruiting60 enrolled